Bionanao Genomics Inc (BNGO): $BNGO CEO of Bionano, commented, “The q...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	898
Posts	148973
Boards Moderated	0
Alias Born	08/13/2010

BottomBounce

Re: Actualfactual post# 1529

Thursday, 12/05/2019 8:52:01 AM

Thursday, December 05, 2019 8:52:01 AM

$BNGO CEO of Bionano, commented, “The quality of the studies presented and wide variety of applications for Saphyr in genetic disease and cancer research is continuing to increase. Data generated by the Saphyr system are answering difficult questions in complex genetic diseases that have been historically very challenging according to each of the presenters who described their experiences with Saphyr. The validation studies for FSHD, repeat expansion disorders and hematological malignancies are setting the stage for Saphyr to become a routine tool in research and clinical settings. We are grateful to all our customers and collaborators for their inspiration and for their work in showing what Saphyr can do.”

More information about Bionano Genomics is available at www.bionanogenomics.com .

$BNGO https://bionanogenomics.com/wp-content/uploads/2019/09/Bionano-Genomics-GenomeWeb-Dr-Jim-Broach-Webinar-White-Paper_0919.pdf

Nothing I say, post, or do should ever be considered financial advice. I may be holding a long, short or no position. I am NOT or NEVER have I been compensated to post on here or anywhere and all my posts are for entertainment purposes only.